Information

Our company has been engaged in the development of measurement technology for completely non-contact, non-invasive blood testing information based on mathematical sciences for over a decade. On August 29, 2025, we will present our technology at the national conference of the Japanese Society of Laboratory Medicine. Starting from the end of September 2025, we will …

Read more “The iOS version of the LDL cholesterol app has been completed.”

Our company presented a study on the non-contact, non-invasive measurement of HbA1c at the Annual Meeting of the Japan Society of Clinical Chemistry held on August 29, 2025. By the end of September 2025, we released an Android application, “FLD HbA1c,” through the SFM App Store, and we are currently offering the app in 18 …

Read more “Exhibition/Presentation at the Medical Conference Forum”

We have released “FLD HbA1c” on our app store, “SFM App Store,” since the end of September 2025. With increasing attention from overseas, we have significantly revamped our website on December 2, 2025, to enable global accessibility. In 2026, we aim to further contribute to the world with presentations on LDL cholesterol at academic conferences, …

Read more “Website Renewal”

For over ten years, our company has been developing technology for completely non-contact and non-invasive blood test information measurement, grounded in mathematical and neuroscientific principles. On August 29, 2025, we will present our technology at the Annual Meeting of the Japanese Association of Clinical Laboratory Medicine, and starting from the end of September 2025, we …

Read more “The Android version of the LDL Cholesterol App has been completed.”

After extensive foundational research, SFM Corporation independently developed the Android app “FLD HbA1c,” which was launched in seven countries across Southeast and Southwest Asia on October 22, 2025. Subsequently, it was released in five countries within the Asia-Oceania region on November 3, 2025, and in four countries within the Asia-Central America region on November 16, …

Read more “We have increased the number of foreign countries where FLD HbA1c is available.”

Since the end of September 2025, we have been releasing our independently developed FLD HbA1c app on the SFM App Store, following many years of foundational research. This app adopts a subscription model. Given the increasing issues related to subscription cancellations in recent years, we would like to take this opportunity to explain our cancellation …

Read more “Regarding Our Subscription”

The Life Biomedical Science Advisors and Sub-Advisors will be involved in the development and research of new fields related to our future-oriented advanced technologies. We are delighted to welcome TEMIZOZ Burcu, a promising researcher and Assistant Professor at the Institute of Medical Science, The University of Tokyo, to join us as a Life Science Sub-Advisor. …

Read more “We are pleased to announce that two researchers have been preliminarily selected for the positions of Life Biomedical Science Advisor and Sub-Advisor as previously mentioned in our press release.”

After years of foundational research, our company made a presentation at the Japanese Society of Laboratory Medicine’s national conference on August 29, 2025. By the end of September 2025, we commenced the release of FLD HbA1c through our app store, ‘SFM App Store.’ Since the launch of the SFM App Store, the number of access …

Read more “SFM App Store Access: Over 150,000 Access Requests in 40 Days”

A portion of our innovative technology was presented at the nationwide conference of the Japanese Society of Laboratory Medicine in August 2025. Furthermore, in September 2025, we commenced the release of the Android-based application “FLD HbA1c.” Additionally, on October 22, 2025, we began releasing the “FLD HbA1c” app in seven countries across Southeast and Southwest …

Read more “Regarding the Appointment of Life Medical Science Advisors and Sub – Advisors”

We are pleased to announce the expansion of release countries within Asia and Central America. The countries included are as follows: The app can be installed from the SFM App Store. SFM App Store We plan to continue increasing the number of release countries, and will provide updates via press releases as more countries are …

Read more “We have expanded the foreign target countries for FLD HbA1c.[the third phase]”